Trupanion Inc (TRUP) was Reiterated by Stifel to “Buy” according to the research note released today. The brokerage firm has raised the Price Target to $ 17 from a previous price target of $16 . Stifel advised their investors in a research report released on May 4, 2016.
On the company’s financial health, Trupanion Inc reported $-0.11 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Feb 11, 2016. Analyst had a consensus of $-0.12. The company had revenue of $40.20 million for the quarter, compared to analysts expectations of $40.42 million. The company’s revenue was up 26.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.16 EPS.
Trupanion Inc opened for trading at $12.56 and hit $12.63 on the upside on Monday, eventually ending the session at $12.55, with a gain of 0.64% or 0.08 points. The heightened volatility saw the trading volume jump to 1,04,467 shares. Company has a market cap of $356 M.
In a different news, on Apr 22, 2016, Darryl Rawlings (President and CEO) sold 3,500 shares at $12.15 per share price. According to the SEC, on Feb 24, 2016, Robin A Ferracone (director) purchased 8,000 shares at $9.35 per share price. On Feb 24, 2016, Craig Susen (Chief Technology Officer) sold 32,752 shares at $8.98 per share price, according to the Form-4 filing with the securities and exchange commission.
Trupanion Inc. is a direct-to-consumer monthly subscription service company engaged in providing a medical insurance plan for cats and dogs across the United States Canada and Puerto Rico. The Company operates through two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions related to medical insurance plan for cats and dogs. The other business segment includes other operations such as writing of policies for an unaffiliated general agent and policies written under a federal Government program.